Skip to content
Wearables & measurementValidation study/review3 min read

One person's 24 hours: Apple Watch 3 and Fitbit Charge 2 heart rate within 10% of ECG

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Accuracy of Consumer Wearable Heart Rate Measurement During an Ecologically Valid 24-Hour Period: Intraindividual Validation Study. · JMIR mHealth and uHealth · 2019 · Original paper ↗

Key takeaway

Over 24 hours in a single participant, the Apple Watch 3 differed from an ambulatory ECG by -1.80 bpm on average and the Fitbit Charge 2 by -3.47 bpm, with mean absolute error near 6% for both. With one person (the first author) and two devices, this is a preliminary check that cannot be generalized.

Study design

Validation study/review

Reading basis

Published abstract

Reading focus

Reference & error

The research question

Wearable heart rate accuracy is usually tested on a treadmill or bike in a lab, not across a normal day with chores and sleep. The authors tested how closely two popular wrist devices tracked a gold-standard ECG over a continuous 24-hour period of realistic use.

Who and how

Single-subject validation study: one participant (the first author, a 29-year-old Caucasian man) wore an Apple Watch 3 and a Fitbit Charge 2 for 24 hours together with an ambulatory ECG (Vrije Universiteit Ambulatory Monitoring System) as the reference, giving 102,740 heartbeats. Data were split into 5 conditions: sitting, walking, running, activities of daily living (such as chores and brushing teeth) and sleeping. Accuracy was measured with mean error, mean absolute error and mean absolute percent error, plus Bland-Altman analyses and concordance correlation for agreement.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Apple Watch 3 versus ECG over 24 hours: mean difference -1.80 beats per minute (bpm), mean absolute error 5.86% and mean agreement 95%.
  2. 2
    Fitbit Charge 2 versus ECG over 24 hours: mean difference -3.47 bpm, mean absolute error 5.96% and mean agreement 91%.
  3. 3
    Both devices stayed within the authors' acceptable accuracy of <±10% across the 24 hours and in each condition, except the Apple Watch 3 during activities of daily living.
  4. 4
    Results varied by condition, so a good 24-hour average does not mean every activity was tracked equally well.

Limits & uncertainty

  1. 1
    Only one participant, who was also the first author, wore the devices, so results may not apply to other skin tones, wrist sizes, fit or heart rhythms.
  2. 2
    Only two older models (Apple Watch 3, Fitbit Charge 2) were tested, so newer devices and firmware are not covered.
  3. 3
    One 24-hour period captures one day of conditions; the authors call the findings preliminary.
  4. 4
    This reading is based on the abstract only, which does not give the per-condition numbers.

What to take from it

These results suggest wrist heart rate from these two devices was reasonably close to an ECG for one person across a normal day, which supports using them for research and general tracking. They do not show that your own device is that accurate, and they do not support using wearable heart rate for diagnosis.

Reading your own data

Resting and daily heart rate from your watch is best read as a trend on the same device, worn the same way (snug, same wrist). Expect more error during chores and other irregular arm movement, and treat single readings with caution.

How to read this evidence

Agreement is specific to the device, firmware, reference, population and setting. Correlation is not agreement, and validating a metric is not proof of diagnostic or treatment benefit.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Wrist-worn smart watches and fitness monitors (ie, wearables) have become widely adopted by consumers and are gaining increased attention from researchers for their potential contribution to naturalistic digital measurement of health in a scalable, mobile, and unobtrusive way. Various studies have examined the accuracy of these devices in controlled laboratory settings (eg, treadmill and stationary bike); however, no studies have investigated the heart rate accuracy of wearables during a continuous and ecologically valid 24-hour period of actual consumer device use conditions.

Objective

The aim of this study was to determine the heart rate accuracy of 2 popular wearable devices, the Apple Watch 3 and Fitbit Charge 2, as compared with the gold standard reference method, an ambulatory electrocardiogram (ECG), during consumer device use conditions in an individual. Data were collected across 5 daily conditions, including sitting, walking, running, activities of daily living (ADL; eg, chores, brushing teeth), and sleeping.

Methods

One participant, (first author; 29-year-old Caucasian male) completed a 24-hour ecologically valid protocol by wearing 2 popular wrist wearable devices (Apple Watch 3 and Fitbit Charge 2). In addition, an ambulatory ECG (Vrije Universiteit Ambulatory Monitoring System) was used as the gold standard reference method, which resulted in the collection of 102,740 individual heartbeats. A single-subject design was used to keep all variables constant except for wearable devices while providing a rapid response design to provide initial assessment of wearable accuracy for allowing the research cycle to keep pace with technological advancements. Accuracy of these devices compared with the gold standard ECG was assessed using mean error, mean absolute error, and mean absolute percent error. These data were supplemented with Bland-Altman analyses and concordance class correlation to assess agreement between devices.

Results

The Apple Watch 3 and Fitbit Charge 2 were generally highly accurate across the 24-hour condition. Specifically, the Apple Watch 3 had a mean difference of -1.80 beats per minute (bpm), a mean absolute error percent of 5.86%, and a mean agreement of 95% when compared with the ECG across 24 hours. The Fitbit Charge 2 had a mean difference of -3.47 bpm, a mean absolute error of 5.96%, and a mean agreement of 91% when compared with the ECG across 24 hours. These findings varied by condition.

Conclusions

The Apple Watch 3 and the Fitbit Charge 2 provided acceptable heart rate accuracy (<±10%) across the 24 hour and during each activity, except for the Apple Watch 3 during the daily activities condition. Overall, these findings provide preliminary support that these devices appear to be useful for implementing ambulatory measurement of cardiac activity in research studies, especially those where the specific advantages of these methods (eg, scalability, low participant burden) are particularly suited to the population or research question.

Sources & attribution

Accuracy of Consumer Wearable Heart Rate Measurement During an Ecologically Valid 24-Hour Period: Intraindividual Validation Study.

Nelson BW, Allen NB.

JMIR mHealth and uHealth · 2019-03-11

DOI: 10.2196/10828 ↗PubMed · 30855232 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Cohort study

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

In-depth explainersRead study →
·Validation study/review

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

In-depth explainersRead study →
·Overview of reviews

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

In-depth explainersRead study →
·Validation study/review

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

In-depth explainersRead study →
Wearables & measurement →